CERRONE GABRIELE M
SEC CIK 1139306 · EDGAR
BoughtSold
Most active insiders at OKYO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | CERRONE GABRIELE M | Dir, 10% | $67.6K | — |
| 2 | Mantelli Flavio | Chief MEDICAL Off | $28.0K | — |
| 3 | Dempsey Robert John | CEO, Dir | $23.1K | — |
| 4 | BRANCACCIO JOHN P | Dir | $7,385 | — |
| 5 | Patil Rajkumar V. | CSO | $5,011 | — |
| 6 | JACOB GARY S | Chief DEVELOPMENT Off, Dir | $4,900 | — |
Transactions 14
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AI | 2026-08-07 16:16 | 2026-07-21 | TLSA | Tiziana Life Sciences Ltd | CERRONE GABRIELE M | Dir, 10% | P - Purchase | $0.99 | +42.4K | 44.81M | +0.1% | +$41.9K |
| AI | 2026-08-07 16:15 | 2026-07-21 | OKYO | OKYO Pharma Ltd | CERRONE GABRIELE M | Dir, 10% | P - Purchase | $1.45 | +22.5K | 10.87M | +0.2% | +$32.6K |
| AI | 2026-08-07 16:15 | 2026-07-20 | OKYO | OKYO Pharma Ltd | CERRONE GABRIELE M | Dir, 10% | P - Purchase | $1.40 | +25.0K | 10.85M | +0.2% | +$35.0K |
| AI | 2026-08-07 16:15 | 2026-06-12 | TLSA | Tiziana Life Sciences Ltd | CERRONE GABRIELE M | Dir, 10% | P - Purchase | $1.11 | +15.0K | 44.77M | +0.0% | +$16.6K |
| I | 2026-07-23 16:15 | 2026-07-21 | TLSA | Tiziana Life Sciences Ltd | CERRONE GABRIELE M | Dir, 10% | A - Grant | $0.99 | +42.4K | 44.81M | +0.1% | +$41.9K |
| I | 2026-07-23 16:15 | 2026-07-21 | OKYO | OKYO Pharma Ltd | CERRONE GABRIELE M | Dir, 10% | A - Grant | $1.45 | +22.5K | 10.87M | +0.2% | +$32.6K |
| I | 2026-07-21 16:15 | 2026-07-20 | OKYO | OKYO Pharma Ltd | CERRONE GABRIELE M | Dir, 10% | A - Grant | $1.40 | +25.0K | 10.85M | +0.2% | +$35.0K |
| I | 2026-06-17 06:31 | 2026-06-12 | TLSA | Tiziana Life Sciences Ltd | CERRONE GABRIELE M | Dir, 10% | A - Grant | $1.11 | +15.0K | 44.77M | +0.0% | +$16.6K |
| I | 2026-06-10 16:30 | 2026-06-08 | OKYO | OKYO Pharma Ltd | CERRONE GABRIELE M | Dir, 10% | A - Grant | $1.72 | +300.0K | 10.83M | +3% | +$516.0K |
| MI | 2023-10-31 | 2023-10-23+ | OKYO | OKYO Pharma Ltd | CERRONE GABRIELE M | Executive COB, Dir | J - Other | $1.50 | +569.5K | 9.11M | +7% | +$854.3K |
| I | 2022-05-20 | 2022-05-19 | OKYO | OKYO Pharma Ltd | CERRONE GABRIELE M | Executive COB, Dir | P - Purchase | $0.08 | +5.80M | 548.98M | +1% | +$464.0K |
| I | 2022-05-19 | 2022-05-19 | OKYO | OKYO Pharma Ltd | CERRONE GABRIELE M | Non-Executive COB, Dir, 10% | P - Purchase | $4.00 | +37.5K | 62.5K | +150% | +$150.0K |
| AI | 2022-05-18 | 2022-05-17 | OKYO | OKYO Pharma Ltd | CERRONE GABRIELE M | Non-Executive COB, Dir, 10% | P - Purchase | $3.87 | +25.0K | 25.0K | New | +$96.8K |
| I | 2022-05-18 | 2022-05-17 | OKYO | OKYO Pharma Ltd | CERRONE GABRIELE M | Non-Executive COB, Dir, 10% | P - Purchase | $0.06 | +1.62M | 544.81M | +0.3% | +$97.5K |
Purchase Sale Sale after option exercise All abbreviations